<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="antithesis" type="rst"/>
			<rel name="condition" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">6. HIF and Vascular Diseases</segment>
<segment id="2" parent="1002" relname="span">In vascular pathology , hypoxia is typically the consequence of altered , destroyed or absent blood vessels</segment>
<segment id="3" parent="2" relname="elaboration">leading to tissue ischemia .</segment>
<segment id="4" parent="1004" relname="span">The mechanisms of the HIF response have therefore been studied in ischemic vascular diseases , such as myocardial infarction</segment>
<segment id="5" parent="1006" relname="joint">( consequence of obstruction of coronary arteries )</segment>
<segment id="6" parent="1006" relname="joint">or peripheral vascular disease</segment>
<segment id="7" parent="1007" relname="span">( PAD , consequence of obstruction of arteries</segment>
<segment id="8" parent="7" relname="elaboration">going to the limbs ) .</segment>
<segment id="9" parent="1001" relname="joint">Besides tissue ischemia ,</segment>
<segment id="10" parent="1010" relname="span">mechanisms of hypoxia and ischemia can occur within the vascular wall itself , with implications for diseases such as atherosclerosis , arterial aneurysm , chronic venous insufficiency and thromboembolism .</segment>
<segment id="11" parent="1011" relname="span">There is growing evidence</segment>
<segment id="12" parent="1012" relname="joint">that the HIF pathway is implicated</segment>
<segment id="13" parent="1014" relname="preparation">— for better or for worse — in the response of the vascular wall to inadequate oxygenation and/or increased cellular oxygen ,</segment>
<segment id="14" parent="1015" relname="span">a demand</segment>
<segment id="15" parent="14" relname="elaboration">secondary to various stresses or injuries .</segment>
<segment id="16" parent="1016" relname="joint">6.1.</segment>
<segment id="17" parent="1018" relname="attribution">HIF and Atherosclerosis</segment>
<segment id="18" parent="1019" relname="span">Atherosclerosis is a condition</segment>
<segment id="19" parent="1020" relname="span">in which fatty deposits</segment>
<segment id="20" parent="19" relname="elaboration">( plaques )</segment>
<segment id="21" parent="1021" relname="joint">develop in the arterial wall ,</segment>
<segment id="22" parent="1021" relname="joint">leading to stenosis and ultimately to thrombosis of the vessel .</segment>
<segment id="23" parent="1001" relname="joint">Atherosclerotic plaques are mainly composed of cholesterol , other lipids , calcium , fibrin and inflammatory cells .</segment>
<segment id="24" parent="1001" relname="joint">Oxygen diffusion through space-occupying atherosclerotic plaques could be limited due to wall thickening .</segment>
<segment id="25" parent="1025" relname="span">Hypoxia could also originate from the high oxygen demand of metabolically active inflammatory cells , such as macrophage foam cells</segment>
<segment id="26" parent="25" relname="elaboration">that play a pivotal role in this disease .</segment>
<segment id="27" parent="1027" relname="span">Detection of HIF-1α and activation of its target genes occurs in atherosclerotic plaques .</segment>
<segment id="28" parent="1029" relname="span">During atherogenesis</segment>
<segment id="29" parent="28" relname="elaboration">( plaque build-up ) ,</segment>
<segment id="30" parent="1030" relname="joint">hypoxia increases angiogenesis ,</segment>
<segment id="31" parent="1031" relname="same_unit">releases pro-inflammatory mediators ,</segment>
<segment id="32" parent="1032" relname="joint">activates MMPs ,</segment>
<segment id="33" parent="1033" relname="joint">forms reactive oxygen species ,</segment>
<segment id="34" parent="1033" relname="joint">and oxidizes low-density lipoprotein .</segment>
<segment id="35" parent="1001" relname="joint">Necrotic cores within atherosclerotic plaques can lead to plaque instability and thromboembolic complications .</segment>
<segment id="36" parent="1001" relname="joint">The HIF-1α protein is found in tissue surrounding atherosclerotic arteries , inflammatory macrophages and arterial SMCs around these necrotic cores .</segment>
<segment id="37" parent="1037" relname="span">Proangiogenic HIF-target genes , such as VEGF-A , are responsible for intra-plaque neoangiogenesis ,</segment>
<segment id="38" parent="37" relname="elaboration">contributing to plaque instability .</segment>
<segment id="39" parent="1001" relname="joint">HIF-1 activity also alters the lipid metabolism of macrophages and vascular SMC .</segment>
<segment id="40" parent="1001" relname="joint">Finally , besides hypoxia , several non-hypoxic stimuli of HIF have also been found in plaques and plaque macrophages , such as inflammation , ROS , vasoactive and thrombotic factors .</segment>
<segment id="41" parent="1001" relname="joint">6.2.</segment>
<segment id="42" parent="1042" relname="preparation">HIF and NH in Vascular Grafts</segment>
<segment id="43" parent="1043" relname="span">The role of the HIF pathway in the development of NH has also been studied .</segment>
<segment id="44" parent="1045" relname="circumstance">When atherosclerotic lesions occupy a long segment of the artery ,</segment>
<segment id="45" parent="1046" relname="span">surgeons frequently use a graft</segment>
<segment id="46" parent="45" relname="purpose">to bypass the lesion</segment>
<segment id="47" parent="1045" relname="joint">and provide blood to distal tissues .</segment>
<segment id="48" parent="1048" relname="span">Either venous or prosthetic ,</segment>
<segment id="49" parent="48" relname="elaboration">these grafts are prone to NH .</segment>
<segment id="50" parent="1051" relname="concession">Although vein grafts and prosthetic grafts are not identical ,</segment>
<segment id="51" parent="1051" relname="span">because of different hemodynamics and oxygen tension ,</segment>
<segment id="52" parent="1052" relname="span">the characteristics of NH in vein grafts are similar to those of NH</segment>
<segment id="53" parent="52" relname="elaboration">that form in AVFs .</segment>
<segment id="54" parent="1054" relname="preparation">In studies with animal models , grafts showed increased hypoxia within the vessel wall in regions of neointimal hyperplasia .</segment>
<segment id="55" parent="1055" relname="span">A study</segment>
<segment id="56" parent="1056" relname="joint">using a porcine model showed an association of HIF-1α expression with the degree of neointimal hyperplasia in grafts ,</segment>
<segment id="57" parent="1058" relname="attribution">and suggested</segment>
<segment id="58" parent="1058" relname="span">that reducing hypoxia might inhibit venous NH formation ,</segment>
<segment id="59" parent="58" relname="means">possibly by reducing the phenotypic switch of fibroblasts to myofibroblasts .</segment>
<segment id="60" parent="1054" relname="joint">Paradoxically , increased activation of the HIF pathway may also protect against NH formation .</segment>
<segment id="61" parent="1061" relname="span">Nakao et al. studied the role of carbon monoxide , a physiologically important vasodilator</segment>
<segment id="62" parent="61" relname="elaboration">that acts via cyclic guanosine monophosphate , in the formation of NH .</segment>
<segment id="63" parent="1064" relname="attribution">They showed</segment>
<segment id="64" parent="1066" relname="span">that a vein graft</segment>
<segment id="65" parent="64" relname="elaboration">placed immediately after harvest led to less NH</segment>
<segment id="66" parent="1066" relname="antithesis">than</segment>
<segment id="67" parent="1065" relname="condition">if the graft was rinsed with lactated Ringer for 2 h prior to surgical placement .</segment>
<segment id="68" parent="1068" relname="same_unit">However ,</segment>
<segment id="69" parent="1070" relname="condition">if the lactated Ringer solution was saturated with carbon monoxide ,</segment>
<segment id="70" parent="1070" relname="span">it significantly inhibited NH</segment>
<segment id="71" parent="70" relname="elaboration">compared to the untreated control .</segment>
<segment id="72" parent="1073" relname="span">The effects of carbon monoxide</segment>
<segment id="73" parent="72" relname="elaboration">in inhibiting NH formation seemed to be associated with increased HIF-1α and VEGF expression a few hours after grafting .</segment>
<segment id="74" parent="1074" relname="span">This effect , including the induction of VEGF , was reversed by treatment with YC-1 , a HIF-1α inhibitor ,</segment>
<segment id="75" parent="1075" relname="span">supporting the conclusion</segment>
<segment id="76" parent="75" relname="elaboration">that these effects were mediated through the activation of the HIF pathway .</segment>
<segment id="77" parent="1077" relname="attribution">These apparently contradictory studies suggest</segment>
<segment id="78" parent="1077" relname="joint">that , at least in the setting of vein graft NH , transient activation of the HIF pathway may protect the wall from hypoxia ,</segment>
<segment id="79" parent="1077" relname="joint">whereas chronic activation may maintain the ongoing NH process .</segment>
<segment id="80" parent="1079" relname="span">Carbon monoxide may also display vasoconstrictor effects</segment>
<segment id="81" parent="1081" relname="span">depending on oxygen and metabolic homeostasis ,</segment>
<segment id="82" parent="81" relname="elaboration">including ROS production ,</segment>
<segment id="83" parent="1080" relname="joint">highlighting the important role of metabolism in the vascular wall .</segment>
<group id="1000" type="span" />
<group id="1001" type="multinuc" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1001" relname="joint"/>
<group id="1004" type="span" parent="1001" relname="joint"/>
<group id="1005" type="multinuc" parent="4" relname="elaboration"/>
<group id="1006" type="multinuc" parent="1005" relname="same_unit"/>
<group id="1007" type="span" parent="1005" relname="same_unit"/>
<group id="1010" type="span" parent="1001" relname="joint"/>
<group id="1011" type="span" parent="10" relname="elaboration"/>
<group id="1012" type="multinuc" parent="11" relname="elaboration"/>
<group id="1013" type="span" parent="1012" relname="joint"/>
<group id="1014" type="span" parent="1013" relname="span"/>
<group id="1015" type="span" parent="1014" relname="span"/>
<group id="1016" type="multinuc" parent="1015" relname="elaboration"/>
<group id="1017" type="span" parent="1016" relname="joint"/>
<group id="1018" type="multinuc" parent="1017" relname="span"/>
<group id="1019" type="span" parent="1018" relname="same_unit"/>
<group id="1020" type="span" parent="18" relname="elaboration"/>
<group id="1021" type="multinuc" parent="1018" relname="same_unit"/>
<group id="1025" type="span" parent="1001" relname="joint"/>
<group id="1027" type="span" parent="1001" relname="joint"/>
<group id="1028" type="multinuc" parent="27" relname="elaboration"/>
<group id="1029" type="span" parent="1028" relname="same_unit"/>
<group id="1030" type="multinuc" parent="1028" relname="same_unit"/>
<group id="1031" type="multinuc" parent="1030" relname="joint"/>
<group id="1032" type="multinuc" parent="1031" relname="same_unit"/>
<group id="1033" type="multinuc" parent="1032" relname="joint"/>
<group id="1037" type="span" parent="1001" relname="joint"/>
<group id="1041" type="span" parent="1001" relname="joint"/>
<group id="1042" type="multinuc" parent="1041" relname="span"/>
<group id="1043" type="span" parent="1042" relname="joint"/>
<group id="1044" type="span" parent="43" relname="elaboration"/>
<group id="1045" type="multinuc" parent="1044" relname="span"/>
<group id="1046" type="span" parent="1045" relname="joint"/>
<group id="1048" type="span" parent="1042" relname="joint"/>
<group id="1050" type="span" parent="1042" relname="joint"/>
<group id="1051" type="span" parent="1050" relname="span"/>
<group id="1052" type="span" parent="51" relname="elaboration"/>
<group id="1053" type="span" parent="1042" relname="joint"/>
<group id="1054" type="multinuc" parent="1053" relname="span"/>
<group id="1055" type="span" parent="1054" relname="joint"/>
<group id="1056" type="multinuc" parent="55" relname="elaboration"/>
<group id="1057" type="span" parent="1056" relname="joint"/>
<group id="1058" type="span" parent="1057" relname="span"/>
<group id="1061" type="span" parent="1054" relname="joint"/>
<group id="1062" type="multinuc" parent="1054" relname="joint"/>
<group id="1063" type="span" parent="1062" relname="contrast"/>
<group id="1064" type="span" parent="1063" relname="span"/>
<group id="1065" type="span" parent="1064" relname="span"/>
<group id="1066" type="span" parent="1065" relname="span"/>
<group id="1067" type="multinuc" parent="1062" relname="contrast"/>
<group id="1068" type="multinuc" parent="1067" relname="joint"/>
<group id="1069" type="span" parent="1068" relname="same_unit"/>
<group id="1070" type="span" parent="1069" relname="span"/>
<group id="1072" type="span" parent="1067" relname="joint"/>
<group id="1073" type="span" parent="1072" relname="span"/>
<group id="1074" type="span" parent="1073" relname="elaboration"/>
<group id="1075" type="span" parent="74" relname="elaboration"/>
<group id="1076" type="span" parent="1067" relname="joint"/>
<group id="1077" type="multinuc" parent="1076" relname="span"/>
<group id="1079" type="span" parent="1077" relname="joint"/>
<group id="1080" type="multinuc" parent="80" relname="condition"/>
<group id="1081" type="span" parent="1080" relname="joint"/>
	</body>
</rst>
